Company · CIK 0000884629
Allergan Finance LLC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
NV
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13GActavis, Inc.0000902219-15-000044 · 21.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-13-435426 · 17.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-13-419835 · 7.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-13-414339 · 298.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-13-406758 · 13.2 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015068 · 5.4 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015067 · 5.5 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015066 · 5.4 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015065 · 5.4 KBSEC(opens sec.gov)
- 4Insider trades0001179110-13-015064 · 5.3 KBSEC(opens sec.gov)
Insiders
- AMATO LYNNEVP, Brand Sales & Operations
- Bisaro PaulDirector, President & CEO
- BODINE CHRIS WDirector
- BOYER ANDREW SSVP,Sales&Mktg,US Generics
- BRITT DONALD ASr. VP, Quality Assurance
- Brunner Patrick G.SVP,Manufacturing Operations
- BUCHEN DAVID AChief Legal Officer-Global&Sec
- Carmichael ClareSR VP, Human Resources
- CHAO ALLENDirector, Executive Chairman
- CHOW YEE MARIASr. VP, New Product Intro/Oper
Tickers
No tickers on record.
Addresses
business
MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY
PARSIPPANY, NJ, 07054
mailing
MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY
PARSIPPANY, NJ, 07054
Former names
- Actavis, Inc.2015-03-05
- WATSON PHARMACEUTICALS INC2013-01-14
Same industry